Manufacturer record
Biomax Biotechnics (P) Ltd. 261: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Biomax Biotechnics (P) Ltd. 261 (Haryana) were declared Not of Standard Quality between February 2020 and April 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: BBT240427A, Telmisartan & Amlodipine Tablets IP (XTEL-AM) (exp Apr 2026). DTL Baddi (state lab) found it not of standard quality: The sample does not conform to the claim as per IP 2022 in respect to Dissolution Test of Amlodipine. Listed in the April 2025 alert.
Records by type
5 records linked to Biomax Biotechnics (P) Ltd. 261 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Telmisartan & Amlodipine Tablets IP (XTEL-AM) | Batch BBT240427AMfg May 2024 · Exp Apr 2026 | The sample does not conform to the claim as per IP 2022 in respect to Dissolution Test of AmlodipineDissolution | DTL BaddiState lab | Apr 2025 |
| Albendazole Tablets I.P. 400 mg | Batch BBT19327AMfg Aug 2019 · Exp Jul 2021 | DissolutionDissolution | RDTL GuwahatiState lab | Mar 2020 |
| Albendazole 400mg. Tablets I.P. | Batch BBT19329AMfg Aug 2019 · Exp Jul 2021 | DissolutionDissolution | RDTL GuwahatiState lab | Feb 2020 |
| Albendazole 400 mg. Tablets I.P. | Batch BBT19326AMfg Aug 2019 · Exp Jul 2021 | DissolutionDissolution | RDTL GuwahatiState lab | Feb 2020 |
| Albendazole 400 mg. Tablets I.P. | Batch BBT19331AMfg Aug 2019 · Exp Jul 2021 | DissolutionDissolution | RDTL GuwahatiState lab | Feb 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.